Immunosuppressive Agents: all 5,940 studies that test it
Page 19 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Biomarker Trial of Everolimus in Patients With Advanced Renal Cell CarcinomaCompletedNCT00827359Phase 2Results posted
- Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerTerminatedNCT00827099Phase 2Results posted
- Preoperative Etanercept Before Inguinal Hernia SurgeryCompletedNCT00825344Not applicableResults posted
- Everolimus in Treating Patients With Recurrent Low-Grade GliomaCompletedNCT00823459Phase 2Results posted
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and ThymoglobulinCompletedNCT00822770Phase 1/2Results posted
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin LymphomaCompletedNCT00822120Phase 2Results posted
- Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver TransplantationCompletedNCT00821587Phase 4Results posted
- Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerTerminatedNCT00818961Phase 2Results posted
- Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice DailyCompletedNCT00817206Phase 3Results posted
- Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00816595Phase 2Results posted
- Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT00814788Phase 2Results posted
- Efficacy of Methotrexate in Myasthenia GravisCompletedNCT00814138Phase 2Results posted
- Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers SyndromeTerminatedNCT00811590Phase 2Results posted
- Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple SclerosisCompletedNCT00811395Phase 2Results posted
- Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell TransplantCompletedNCT00810602Phase 1/2Results posted
- A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate TreatmentCompletedNCT00810199Phase 3Results posted
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's LymphomaTerminatedNCT00809341Phase 2Results posted
- Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCYCompletedNCT00809276Phase 1/2Results posted
- RAD001(Everolimus) in Treating Patients With Myelodysplastic SyndromesTerminatedNCT00809185Phase 2Results posted
- Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk NeuroblastomaTerminatedNCT00808899Phase 2Results posted
- Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney TransplantationCompletedNCT00807144Phase 4Results posted
- Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic SyndromeCompletedNCT00806598Phase 2Results posted
- RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBMCompletedNCT00805961Phase 2Results posted
- Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00805129Phase 2Results posted
- Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT00803049Phase 3Results posted
- Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT00803010Phase 2Results posted
- Autologous and Allogeneic Transplant for Relapsed LymphomaCompletedNCT00802113Phase 1/2Results posted
- Double Cord Blood Transplant for Patients With Malignant and Non-malignant DisordersTerminatedNCT00801931Phase 1/2Results posted
- Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideCompletedNCT00800839Phase 2Results posted
- Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)TerminatedNCT00796705Phase 4Results posted
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by ChemotherapyCompletedNCT00796562Phase 2Results posted
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantCompletedNCT00796068Phase 2Results posted
- Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)CompletedNCT00795886Phase 2Results posted
- Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesCompletedNCT00795132Phase 2Results posted
- Fludarabine, Cyclophosphamide, and Rituximab - High Dose FrontlineCompletedNCT00794820Phase 2Results posted
- Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple MyelomaCompletedNCT00792142Phase 2Results posted
- Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791999Phase 2/3Results posted
- Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791921Phase 3Results posted
- Moderate to Severe Plaque Psoriasis With Scalp InvolvementCompletedNCT00791765Phase 4Results posted
- Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)CompletedNCT00790400Phase 3Results posted
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapyCompletedNCT00790036Phase 3Results posted
- TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot TrialCompletedNCT00789997Phase 2/3Results posted
- Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)CompletedNCT00789828Phase 3Results posted
- Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic CancerCompletedNCT00789776Phase 1/2Results posted
- Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerCompletedNCT00787761Phase 2Results posted
- Hematopoietic Stem Cell Transplant in Devic's DiseaseCompletedNCT00787722Phase 1/2Results posted
- Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin LymphomaCompletedNCT00784927Phase 2Results posted
- The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic AsthmaticsCompletedNCT00784459Phase 2Results posted
- Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade GliomasCompletedNCT00782626Phase 2Results posted
- Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerCompletedNCT00782379Phase 2Results posted
- Prospective Study of Rapamycin for the Treatment of SLECompletedNCT00779194Phase 2Results posted
- Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional TherapiesTerminatedNCT00779142Not applicableResults posted
- Allogeneic Transplantation For Severe OsteopetrosisCompletedNCT00775931Phase 2/3Results posted
- Abatacept and Cyclophosphamide Combination Therapy for Lupus NephritisCompletedNCT00774852Phase 2Results posted
- Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITPCompletedNCT00774202Phase 2/3Results posted
- Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)CompletedNCT00773292Phase 2/3Results posted
- Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZLTerminatedNCT00772668Not applicableResults posted
- Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant PatientsCompletedNCT00772148Phase 2Results posted
- Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant RecipientsCompletedNCT00771745Phase 4Results posted
- S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaCompletedNCT00770224Phase 2Results posted
- S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00770120Phase 2Results posted
- Evaluation of EULAR-RAID Score in Rheumatoid Arthritis PatientsCompletedNCT00768053Phase 4Results posted
- Treatment of Patients With RAD001 With Progressive SarcomaCompletedNCT00767819Phase 2Results posted
- A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler UltrasonographyCompletedNCT00767325Phase 3Results posted
- Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMDCompletedNCT00766649Phase 1/2Results posted
- Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant PatientsCompletedNCT00765661Phase 2Results posted
- Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaCompletedNCT00764517Phase 2Results posted
- METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)CompletedNCT00759811Phase 2/3Results posted
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00759798Phase 2Results posted
- A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00754572Phase 3Results posted
- Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)CompletedNCT00753454Phase 3Results posted
- An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple SclerosisCompletedNCT00751881Phase 3Results posted
- Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)CompletedNCT00750815Phase 1/2Results posted
- Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee OsteoarthritisCompletedNCT00746889Not applicableResults posted
- A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced SarcomaCompletedNCT00743509Phase 2Results posted
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic MalignanciesCompletedNCT00741455Not applicableResults posted
- Safety Study of Abatacept to Treat Refractory SarcoidosisTerminatedNCT00739960Phase 2Results posted
- A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral RadiculopathyCompletedNCT00733096Phase 2/3Results posted
- Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)TerminatedNCT00732940Phase 2Results posted
- A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)CompletedNCT00732875Phase 3Results posted
- Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft StatusTerminatedNCT00731874Phase 4Results posted
- This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.TerminatedNCT00731692Phase 3Results posted
- RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line TreatmentCompletedNCT00729482Phase 2Results posted
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00727441Phase 2Results posted
- Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to TherapyCompletedNCT00727415Phase 1/2Results posted
- The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host DiseaseCompletedNCT00726375Phase 3Results posted
- Oral Cladribine in Early Multiple Sclerosis (MS)CompletedNCT00725985Phase 3Results posted
- A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United StatesCompletedNCT00724867Phase 3Results posted
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerCompletedNCT00723099Phase 2Results posted
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseCompletedNCT00719888Phase 2Results posted
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other DiseaseTerminatedNCT00719849Phase 2Results posted
- Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney CancerCompletedNCT00719264Phase 2Results posted
- A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)CompletedNCT00718549Phase 3Results posted
- Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00717236Phase 3Results posted
- Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular LymphomaCompletedNCT00715208Phase 2Results posted
- Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving MyforticCompletedNCT00713284Phase 4Results posted
- Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)CompletedNCT00713193Phase 3Results posted
- A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057CompletedNCT00712933Phase 3Results posted
- Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell LymphomaCompletedNCT00711828Phase 2Results posted
- Sirolimus to Treat Diabetic Macular EdemaCompletedNCT00711490Phase 1/2Results posted